Skip to main content
Log in

Effect of Pentoxifylline In Vitro on Neutrophil Reactive Oxygen Production and Phagocytic Ability Assessed by Flow Cytometry

  • Pharmacodynamics
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Summary

Neutrophil granulocytes have been described as agents of defence and destruction. The effect of pentoxifylline on the phagocytic ability and generation of reactive oxygen radicals of neutrophils was studied at concentrations of 1,10 and 100 mg/L. Flow cytometry was used to study phagocytic ability by measuring uptake of fluorescein-labelled bacteria. The generation of reactive oxygen intermediates was estimated by the quantification of the intracellular conversion of dihydrorhodamine 123 to rhodamine 123. In vitro pentoxifylline treatment diminished neutrophil reactive oxygen production (at 10 mg/L -45% and at 100 mg/L −63%; p < 0.001 for both) and reduced neutrophil phagocytic ability (at 100 mg/L −23%; p < 0.05). Both effects were rapidly reversible after plasma exchange. We conclude that pentoxifylline could decrease oxidative tissue damage by neutrophils in septicaemia or after IV granulocyte transfusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bone RC. Inhibitors of complement and neutrophils: a critical evaluation of their role in the treatment of sepsis. Crit Care Med 1992; 20: 891–8

    Article  PubMed  CAS  Google Scholar 

  2. Buchanan MR, Vasquez MJ, Gimbrone AJ. Arachidonic acid metabolism and the adhesion of human polymorphonuclear leukocytes to cultured vascular endothelial cells. Blood 1983; 62: 889–95

    PubMed  CAS  Google Scholar 

  3. Cronstein BN, Eberle MA, Gruber HE, et al. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991; 88: 2441–5

    Article  PubMed  CAS  Google Scholar 

  4. Cronstein BN, Kimmel SC, Levin RI, et al. A mechanism for the antiinflammatory effects of cortocosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of ELAM-1 and ICAM-1. Proc Natl Acad Sci USA 1992; 89: 9991–5

    Article  PubMed  CAS  Google Scholar 

  5. Issekutz AC, Chuluyan HE, Lopes N. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms. J Leukoc Biol 1995; 57: 553–61

    PubMed  CAS  Google Scholar 

  6. Sullivan GW, Carper HT, Novick WJ, et al. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor alpha on neutrophil function by pentoxifylline. Infect Immun 1988; 56: 1722–9

    PubMed  CAS  Google Scholar 

  7. Graninger W, Wenisch C. Pentoxifylline in severe inflammatory response syndrome. J Cardiovasc Pharmacol 1995; 25: 134–8

    Article  Google Scholar 

  8. Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989; 320: 365–76

    Article  PubMed  CAS  Google Scholar 

  9. Baehner RL, Boxer LA, Allen JM, et al. Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood 1977; 50: 327–35

    PubMed  CAS  Google Scholar 

  10. Sullivan GW, Carper HT, Novick WJ, et al. Pentoxifylline inhibits the inflammatory effects of endotoxin and endotoxininduced cytokines on neutrophil function. In: Mandell GL, Novick WJ, editors. Pentoxifylline and leukocyte function. Somerville, NJ: Hoechst-Roussel Pharmaceuticals Inc.

  11. Wenisch C, Parschalk B, Hasenhündl M, et al. Polymorphonuclear leukocyte dysregulation in patients with Gram-negative septicemia. Eur J Clin Invest 1995; 25: 418–24

    Article  PubMed  CAS  Google Scholar 

  12. Wenisch C, Graninger W. Are soluble factors relevant for PMN dysregulation in patients with Gram-negative septicemia? Clin Lab Diagnost Immunol 1995; 2: 241–5

    CAS  Google Scholar 

  13. Wenisch C, Parschalk B, Hasenhündl M, et al. Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections. Antimicrob Agents Chemother 1995; 39: 672–6

    Article  PubMed  CAS  Google Scholar 

  14. Elbim C, Lefebvre M, Hakim J, et al. Effects of pentoxifylline on human polymorphonuclear neutrophil responses to TNF in whole blood. Eur Cytokine Netw 1995; 6: 113–20

    PubMed  CAS  Google Scholar 

  15. Crouch SPM, Fletcher J. Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect Immun 1992; 60: 4504–9

    PubMed  CAS  Google Scholar 

  16. Sullivan GW, Carper HT, Mandell GL. Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro. Antimicrob Agents Chemother 1992; 36: 408–16

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenisch, C., Zedtwitz-Liebenstein, K., Parschalk, B. et al. Effect of Pentoxifylline In Vitro on Neutrophil Reactive Oxygen Production and Phagocytic Ability Assessed by Flow Cytometry. Clin. Drug Invest. 13, 99–104 (1997). https://doi.org/10.2165/00044011-199713020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-199713020-00006

Keywords

Navigation